Abstract:Immune cell activation triggers signaling cascades leading to transcriptional reprogramming, but also strongly impacts on the cell’s metabolic activity to provide energy and biomolecules for inflammatory and proliferative responses. Macrophages activated by microbial pathogen-associated molecular patterns and cytokines upregulate expression of the enzyme ACOD1 that generates the immune-metabolite itaconate by decarboxylation of the TCA cycle metabolite cis-aconitate. Itaconate has anti-microbial as well as immunomodulatory activities, which makes it attractive as endogenous effector metabolite fighting infection and restraining inflammation. Here, we first summarize the pathways and stimuli inducing ACOD1 expression in macrophages. The focus of the review then lies on the mechanisms by which itaconate, and its synthetic derivatives and endogenous isomers, modulate immune cell signaling and metabolic pathways. Multiple targets have been revealed, from inhibition of enzymes to the post-translational modification of many proteins at cysteine or lysine residues. The modulation of signaling proteins like STING, SYK, JAK1, RIPK3 and KEAP1, transcription regulators (e.g. Tet2, TFEB) and inflammasome components (NLRP3, GSDMD) provides a biochemical basis for the immune-regulatory effects of the ACOD1-itaconate pathway. While the field has intensely studied control of macrophages by itaconate in infection and inflammation models, neutrophils have now entered the scene as producers and cellular targets of itaconate. Furthermore, regulation of adaptive immune responses by endogenous itaconate, as well as by exogenously added itaconate and derivatives, can be mediated by direct and indirect effects on T cells and antigen-presenting cells, respectively. Taken together, research in ACOD1-itaconate to date has revealed its relevance in diverse immune cell signaling pathways, which now provides opportunities for potential therapeutic or preventive manipulation of host defense and inflammation.

The role and therapeutic potential of itaconate in lung disease

The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities.

The Cell Autonomous and Non-Autonomous Roles of Itaconate in Immune Response

Itaconate Regulates Macrophage Function Through Stressful Iron-Sulfur Cluster Disrupting And Iron Metabolism Rebalancing

Itaconate: A Metabolite Regulates Inflammation Response and Oxidative Stress

The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases

Itaconate to treat acute lung injury: recent advances and insights from preclinical models

The potential of using itaconate as treatment for inflammation-related heart diseases

Itaconate Uptake Via SLC13A3 Improves Hepatic Antibacterial Innate Immunity

Itaconate as a key player in cardiovascular immunometabolism

Itaconate is a Lysosomal Inducer That Promotes Antibacterial Innate Immunity.

Inhalation of Itraconazole Mitigates Bleomycin-Induced Lung Fibrosis Via Regulating SPP1 and C3 Signaling Pathway Pivotal in the Interaction Between Phagocytic Macrophages and Diseased Fibroblasts

Metabolite itaconate in host immunoregulation and defense

Metabolic Messengers: itaconate

Metabolic Regulation of Inflammation: Exploring the Potential Benefits of Itaconate in Autoimmune Disorders

The anti-inflammatory effects of itaconate and its derivatives in neurological disorders

Itaconate: the poster child of metabolic reprogramming in macrophage function

Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury

Control of immune cell signaling by the immuno-metabolite itaconate

Itaconate in host inflammation and defense

Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1